메뉴 건너뛰기




Volumn 11, Issue 2, 2003, Pages 123-130

Drug development and Alzheimer disease

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 OXO 1 PYRROLIDINYL) N (5,6,7,8 TETRAHYDRO 2,3 DIMETHYLFURO[2,3 B]QUINOLIN 4 YL)ACETAMIDE; 2 [2 (1 BENZYL 4 PIPERIDINYL)ETHYL] 2,3 DIHYDRO 9 METHOXY 1H PYRROLO[3,4 B]QUINOLIN 1 ONE; 7 METHOXYTACRINE; ABPI 124; AMIRIDINE; AMYLOID; ANSECULIN; APOLIPOPROTEIN E4; ATORVASTATIN; CEREBROLYSIN; DONEPEZIL; ESTROGEN; FASORACETAM; GALANTAMINE; GANSTIGMINE; MEMANTINE; METHANOSULFONYL FLUORIDE; METRIFONATE; MONTIRELIN; NAPROXEN; NICERGOLINE; NIFIRACETAM; P 11149; PHENSERINE; RIVASTIGMINE; ROFECOXIB; TACRINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZANAPEZIL; ZANEPEZIL;

EID: 0037371057     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-200303000-00003     Document Type: Note
Times cited : (16)

References (8)
  • 1
    • 0036833437 scopus 로고    scopus 로고
    • Therapeutic strategies for Alzheimer's disease
    • Wolfe MS: Therapeutic strategies for Alzheimer's disease. Nature Reviews: Drug Discovery 2002; 1:859-866
    • (2002) Nature Reviews: Drug Discovery , vol.1 , pp. 859-866
    • Wolfe, M.S.1
  • 2
    • 0036780877 scopus 로고    scopus 로고
    • Amyloid-beta immunotherapy for Alzheimer's disease: The end of the beginning
    • Schenk D: Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning. Nature Reviews: Neuroscience 2002; 3:824-828
    • (2002) Nature Reviews: Neuroscience , vol.3 , pp. 824-828
    • Schenk, D.1
  • 3
    • 0036633359 scopus 로고    scopus 로고
    • Genome-based pharmacogenetics and the pharmaceutical industry
    • Roses AD: Genome-based pharmacogenetics and the pharmaceutical industry. Nature Reviews: Drug Discovery 2002; 1:541-549
    • (2002) Nature Reviews: Drug Discovery , vol.1 , pp. 541-549
    • Roses, A.D.1
  • 4
    • 12044254746 scopus 로고
    • Binding of human apolipoprotein-E to synthetic amyloid beta peptide: Isoformspecific effects and implications for late-onset Alzheimer disease
    • Strittmatter WJ, Weisgraber KH, Huang DY, et al: Binding of human apolipoprotein-E to synthetic amyloid beta peptide: isoformspecific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A 1993; 90:8098-8102
    • (1993) Proc Natl Acad Sci U S A , vol.90 , pp. 8098-8102
    • Strittmatter, W.J.1    Weisgraber, K.H.2    Huang, D.Y.3
  • 5
    • 0027327267 scopus 로고
    • Association of apolipoprotein-E allele epsilon-4 with late-onset familial and sporadic Alzheimer's disease
    • Saunders AM, Strittmatter WJ, Schmechel D, et al: Association of apolipoprotein-E allele epsilon-4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43:1467-1472
    • (1993) Neurology , vol.43 , pp. 1467-1472
    • Saunders, A.M.1    Strittmatter, W.J.2    Schmechel, D.3
  • 6
    • 0028950856 scopus 로고
    • Apolipoprotein-E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease
    • Small GW, Mazziotta JC, Collins MT, et al: Apolipoprotein-E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 1995; 273:942-947
    • (1995) JAMA , vol.273 , pp. 942-947
    • Small, G.W.1    Mazziotta, J.C.2    Collins, M.T.3
  • 7
    • 0029970342 scopus 로고    scopus 로고
    • Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon-4 allele for apolipoprotein-E
    • Reiman EM, Caselli RJ, Yun LS, et al: Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon-4 allele for apolipoprotein-E. New Engl J Med 1996; 334:752-758
    • (1996) New Engl J Med , vol.334 , pp. 752-758
    • Reiman, E.M.1    Caselli, R.J.2    Yun, L.S.3
  • 8
    • 0033795279 scopus 로고    scopus 로고
    • Apolipoprotein-E and Alzheimer disease: An update on genetic and functional analyses
    • Saunders AM: Apolipoprotein-E and Alzheimer disease: an update on genetic and functional analyses. J Neuropathol Exp Neurol 2000; 59:751-758
    • (2000) J Neuropathol Exp Neurol , vol.59 , pp. 751-758
    • Saunders, A.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.